Lisa A Joss-Moore1, Robert H Lane. 1. Division of Neonatology, Department of Pediatrics,University of Utah, 295 Chipeta Way, 2N131 Salt Lake City, UT 84108, USA.
Abstract
PURPOSE OF REVIEW: Intrauterine growth restriction (IUGR) is associated with an increased propensity to develop adult-onset disease and is described by the developmental origins of adult disease hypothesis. Sequelae of fetal growth restriction include metabolic disease as well as nonmetabolic disorders. Although it has become clear that the morbidities associated with IUGR are complex and result from disruptions to multiple pathways and multiple organs, the mechanisms driving the long-term effects are only just beginning to be understood. RECENT FINDINGS: IUGR affects most organ systems by either interrupting developmental processes such as apoptosis or producing lasting changes to levels of key regulatory factors. Both of these are associated with an often persistent change in gene expression. Epigenetic modulation of transcription is a mechanism that is at least partially responsible for this. IUGR is accompanied by changes in the quantity and activity of enzymes responsible for making modifications to chromatin as well as global and gene-specific modifications of chromatin. SUMMARY: The subtle adjustments needed to ensure developmental plasticity in IUGR are provided by epigenetic modulation of critical genes. Translating the messages of the epigenetic profile and identifying the players that mediate the effects remains one of the major challenges in the field. An understanding of the mechanisms driving the epigenetic changes will facilitate identification of dietary and pharmaceutical approaches that can be applied in the postnatal period.
PURPOSE OF REVIEW: Intrauterine growth restriction (IUGR) is associated with an increased propensity to develop adult-onset disease and is described by the developmental origins of adult disease hypothesis. Sequelae of fetal growth restriction include metabolic disease as well as nonmetabolic disorders. Although it has become clear that the morbidities associated with IUGR are complex and result from disruptions to multiple pathways and multiple organs, the mechanisms driving the long-term effects are only just beginning to be understood. RECENT FINDINGS: IUGR affects most organ systems by either interrupting developmental processes such as apoptosis or producing lasting changes to levels of key regulatory factors. Both of these are associated with an often persistent change in gene expression. Epigenetic modulation of transcription is a mechanism that is at least partially responsible for this. IUGR is accompanied by changes in the quantity and activity of enzymes responsible for making modifications to chromatin as well as global and gene-specific modifications of chromatin. SUMMARY: The subtle adjustments needed to ensure developmental plasticity in IUGR are provided by epigenetic modulation of critical genes. Translating the messages of the epigenetic profile and identifying the players that mediate the effects remains one of the major challenges in the field. An understanding of the mechanisms driving the epigenetic changes will facilitate identification of dietary and pharmaceutical approaches that can be applied in the postnatal period.
Authors: D E Flanagan; V M Moore; I F Godsland; R A Cockington; J S Robinson; D I Phillips Journal: Am J Physiol Endocrinol Metab Date: 2000-04 Impact factor: 4.310
Authors: Mary Pylipow; Logan G Spector; Susan E Puumala; Christopher Boys; Jessica Cohen; Michael K Georgieff Journal: J Pediatr Date: 2008-09-27 Impact factor: 4.406
Authors: L Parker; D W Lamont; N Unwin; M S Pearce; S M A Bennett; H O Dickinson; M White; J C Mathers; K G M M Alberti; A W Craft Journal: Diabet Med Date: 2003-05 Impact factor: 4.359
Authors: Thomas R Magee; Sanaz A Tafti; Mina Desai; Qinghai Liu; Michael G Ross; Cynthia C Nast Journal: Reprod Sci Date: 2011-01-27 Impact factor: 3.060
Authors: Rosemary D Higgins; Sherin Devaskar; William W Hay; Richard A Ehrenkranz; Frank R Greer; Kathleen Kennedy; Paula Meier; LuAnn Papile; Michael P Sherman Journal: J Pediatr Date: 2012-01-10 Impact factor: 4.406